Berardi Cecilia, Bravo Claudio A, Li Song, Khorsandi Maziar, Keenan Jeffrey E, Auld Jonathan, Rockom Sunny, Beckman Jennifer A, Mahr Claudius
Division of Cardiovascular Medicine, Baystate Medical Center, Springfield, MA 01199, USA.
Division of Cardiology, Department of Medicine, University of Washington, Seattle, WA 98195, USA.
J Clin Med. 2022 Apr 5;11(7):2022. doi: 10.3390/jcm11072022.
The utilization of left ventricular assist devices (LVADs) in end-stage heart failure has doubled in the past ten years and is bound to continue to increase. Since the first of these devices was approved in 1994, the technology has changed tremendously, and so has the medical and surgical management of these patients. In this review, we discuss the history of LVADs, evaluating survival and complications over time. We also aim to discuss practical aspects of the medical and surgical management of LVAD patients and future directions for outcome improvement in this population.
在过去十年中，终末期心力衰竭患者使用左心室辅助装置（LVAD）的比例翻了一番，而且势必会继续上升。自1994年首个此类装置获批以来，技术发生了巨大变化，这些患者的医疗和外科治疗方式也同样如此。在这篇综述中，我们讨论LVAD的历史，评估不同时期的生存率和并发症。我们还旨在探讨LVAD患者医疗和外科治疗的实际情况，以及改善这一人群治疗效果的未来方向。
